Top 5 Pharmacy Times Cardiovascular Articles of 2023

News
Article

From newsworthy moments to groundbreaking research, these were the most-read cardiovascular-related articles on Pharmacy Times in 2023.

1. Data Show Effect of Dietary Sodium Reduction on Blood Pressure Was Comparable to First-Line Medication

Clinically meaningful lowering of blood pressure through reduction in dietary sodium was achieved safely and rapidly in 1 week in a middle-aged and elderly cohort. Read More Here.

Doctor Measuring arterial blood pressure man patient Health care in hospital | Image Credit: joyfotoliakid - stock.adobe.com

joyfotoliakid - stock.adobe.com

2. Study: Losing Weight Lowers Risk Factors for CVD, T2D

Health benefits last for at least 5 years if weight loss occurs via a lifestyle change program, the results of a research review show. Read More Here.

3. Daily Low-Dose Aspirin Does Not Significantly Reduce Risk of Stroke, Can Cause Intracranial Bleeding

Study findings contrast with previously reported research linking aspirin to the secondary prevention of stroke, and are especially notable for older adults who may be more susceptible to bleeding-inducing events. Read More Here.

4. FDA Grants Fast Track Designation to Milvexian for Multiple Prospective Cardiovascular Indications

The proposed indications for milvexian include stroke prevention after an acute ischemic stroke or high-risk transient ischemic attack; recent acute coronary syndrome; and atrial fibrillation. Read More Here.

5. Janssen’s Xarelto Demonstrates Consistent Benefits for PAD for Up to 3 Years

Rivaroxaban and aspirin results in a 33% reduction in major adverse limb events both early and late following lower extremity revascularization. Read More Here.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.